跳至主要内容
临床试验/EUCTR2019-003358-10-ES
EUCTR2019-003358-10-ES进行中(未招募)1 期

Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trial

Carmen Olmos Blanco0 个研究点目标入组 298 人开始时间: 2019年11月11日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
298

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Definite IE, according to modified ESC 2015 criteria, caused by gram-positive cocci (staphylococci, streptococci and enterococci), including native, prosthetic valve IE and cardiac device-related IE.
  • I8 years old or older.
  • Absence of fever, microbiological or analytical findings suggesting persistent infection after 24h of randomization.
  • Absence of locally uncontrolled infection signs (abscess, pseudoaneurysm, fistula, enlarging vegetation) at randomization, confirmed by recent transesophageal echocardiography (performed within 48 h of randomization).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 204

排除标准

  • Patients who recived more than 12 days of target antibiotic treatament to infective endocarditis
  • Patients not suitable to be discharged after randomization, due to clinical reasons (sequels of stroke that prevent discharge, progressive renal failure, hepatic failure).
  • Patients with immunosuppressive therapy or chemotherapy
  • Pregnant and breastfeeding women.
  • Need of prolonged antibiotic therapy due to spondylodiscitis.
  • Absence of patient’s ability or commitment to continue follow-up after being discharged from hospital.
  • Inability to give informed consent to participation.
  • Cognitive impairment or Spanish unknowledge
  • Patients candidate to cardiac surgery considered unoperable due to high surgical risk.

研究者

发起方
Carmen Olmos Blanco

相似试验

进行中(未招募)
1 期
Short versus extended antibiotic treatment for fever during low white blood cell counts in hematology patients with fever of unknown origin.Febrile neutropeniaMedDRA version: 19.1Level: PTClassification code 10063581Term: Stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: LLTClassification code 10002969Term: Aplastic anemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.1Level: LLTClassification code 10003999Term: BacteremiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10007810Term: Catheter related infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10028566Term: MyelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10062957Term: Catheter bacteraemiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10024329Term: LeukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: PTClassification code 10056520Term: Catheter site infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2014-001546-25-NLVU University Medical Center240
已完成
4 期
Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiority trial.febrile neutropenia1001886510004018
NL-OMON47609VUmc276
已完成
3 期
Duration of antibiotic therapy in patients with moderate or severe cholangitis
CTRI/2021/05/033535ot applicable120
尚未招募
不适用
Korte versus lange behandeling met een carbapenem voor onverklaarde koorts tijdens hoog risico neutropenie bij hematologische patiënten: een gerandomiseerde non-inferiority studie.
NL-OMON26213VU university medical center224
招募中
不适用
Very short-course versus standard course antibiotic therapy in patients with acute ChOlangitis after adequate endoscopic BiliaRy drAinage (COBRA trial).cholangitis
NL-OMON56128Amsterdam UMC440